NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/06/2023
Voltar para busca
Dado oficial do USPTO
EXOTHERA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/06/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
40, 42
Data de depósito
18/09/2020
Data de registro
24/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/08/2021
Última transação
24/08/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
BE
Examinador
STRUCK, ROBERT
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EXOTHERA, société anonyme
Representantes
Andrew D. Dorisio DICKINSON WRIGHT PLLC
Classificação técnica
Classes Nice
Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Custom manufacturing of biologicsmanufacturing of biologics using biological organisms in the manufacturing process; custom manufacturing of pharmaceuticalsantibiotic medicines and materials for clinical trials and for commercial supply by pharmaceutical compounders; bio manufacturing for otherscustom manufacturing of pharmaceuticals and materials for clinical trials for commercial supplyusing biological organisms in the manufacturing process; custom manufacturing services in the field of biologicspharmaceuticalsbiopharmaceuticalshealth carecell culture and gene therapy and medical products; custom manufacturing of medications and parts of medications on the base of specific compositions or active constituents for others to support clinical trials and commercial supply; treatment of pharmaceutical and chemical products and their components during the custom manufacture of pharmaceuticals and biopharmaceuticals; providing advice related to the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply; providing information in the field of the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply
Classe 42
Scientific research and development applied in particular in the biologicaltechnological and biotechnological fieldsin the medicalbiomedicalchemicalpharmaceutical and veterinary fieldsin the fields of immunologyepidemiologyvaccinology and therapies and in the field of gene and cellular therapy; scientific and technological research and development for the pharmaceutical and biotechnology industries; quality control services on pharmaceutical products for others; scientific research and technological development and advice servicesanalytical testingbiosafety testingreporting and laboratory services for otherscustom design and development of chemical reagents and biochemical assaysformulation and process development for the manufacturing of medicinal products; engineering services; scientific and technological consultancy on process development relating to manufacture of biologics; industrial process development for manufacturing of medical preparations; engineering services and scientific and technological consultancyall on production units for the development of biologics; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; biochemical engineering services; technical engineering services in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; technological development servicestechnology advice and information services and engineering consultation services in the field of the production of biologics; scientific research services in the medical sectorconducting clinical trials for others; providing scientific research information in the medical sectorin the field of clinical trials; scientific laboratory services related to the culture of stem cells or differentiated cells and biological materials to be used in cellular therapies and in clinical trials and for the manufacturing of commercial products
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/02/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/02/2022
FIMP
FINAL DISPOSITION PROCESSED
03/02/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
24/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/06/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/06/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2021
PUBO
PUBLISHED FOR OPPOSITION
08/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/05/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/04/2021
RFNT
REFUSAL PROCESSED BY IB
22/03/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/02/2021
RFRR
REFUSAL PROCESSED BY MPU
26/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/02/2021
CNRT
NON-FINAL ACTION WRITTEN
05/02/2021
DOCK
ASSIGNED TO EXAMINER
03/02/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXOTHERA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.